Oncolytics Biotech (TSE:ONC) Stock Price Crosses Below 200-Day Moving Average – Here’s Why

Oncolytics Biotech Inc. (TSE:ONC) crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of C$14.90 and traded as low as C$14.90. Oncolytics Biotech shares last traded at C$14.90, with a volume of 280 shares traded.

Oncolytics Biotech Stock Performance

The stock has a fifty day moving average price of C$14.90 and a two-hundred day moving average price of C$14.90. The company has a market cap of C$1.50 billion, a P/E ratio of -40.27 and a beta of 0.80. The company has a debt-to-equity ratio of 14.58, a current ratio of 2.88 and a quick ratio of 8.86.

About Oncolytics Biotech

Oncolytics Biotech Inc, a clinical-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 clinical trial for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma. It has a co-development agreement with Merck KGaA and Pfizer Inc to co-develop pelareorep, as well as with Roche Holding AG.